STOCKHOLDERS' EQUITY (Details) - USD ($)		3 Months Ended			9 Months Ended
	Aug. 27, 2025	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2025	Sep. 30, 2024	Jul. 31, 2025
STOCKHOLDERS' EQUITY
Issuance of common stock shares					2,100,699	791,667
Common stock issued upon exercise of warrants shares					5,772,822
Proceeds received exercise of warrant		$ 2,202,345	$ 1,418,973	$ 806,438	$ 4,427,756
Proceeds from stock options exercised					$ 55,000
Cashless share options treated as exercised treasury stock					52,461
Restricted stock awards treated as treasury stock					88,399
Treasury stock issued common share					$ 101,429
Number of cashless shares exercised under share-based compensation award						0
Newly issued common shares with a cost		409,246			409,246
Equity Incentive Plan
STOCKHOLDERS' EQUITY
Stock options granted					2,391,400
Restricted stock units granted during period					2,182,800
Amended And Restated 2023 Equity Incentive Plan
STOCKHOLDERS' EQUITY
Common stock available for issuance shares							23,700,000
Common Stock Warrants
STOCKHOLDERS' EQUITY
Gross proceeds from sales of stock					$ 4,427,756
Weighted average price of shares issued					$ 0.77
Shares, Issued		5,772,822			5,772,822
Employee Stock Option
STOCKHOLDERS' EQUITY
Stock options granted					2,391,400
Unrecognized share-based compensation expense		$ 3,992,315			$ 3,992,315
Weighted-average remaining period					9 months 18 days
Number of options exercised					672,500
Stock options exercised in period, shares					250,000
Proceeds from stock options exercised					$ 55,000
Cashless share options treated as exercised treasury stock					52,461
Number of cashless share options exercised					370,039
Intrinsic value of options exercised					$ 1,410,033
Weighted Average Remaining Contractual Term					5 years 8 months 12 days
Employee Stock Option | Minimum
STOCKHOLDERS' EQUITY
Weighted Average Remaining Contractual Term					3 years
Employee Stock Option | Maximum
STOCKHOLDERS' EQUITY
Weighted Average Remaining Contractual Term					10 years
Restricted stock units
STOCKHOLDERS' EQUITY
Unrecognized share-based compensation expense		$ 4,306,192			$ 4,306,192
Weighted-average remaining period					2 years 1 month 6 days
Nonvested RSU shares (in years)					1 year 6 months
Shares issued pursuant to the vesting of RSUs					1,428,199
Restricted stock awards treated as treasury stock					88,399
At-the-market offering
STOCKHOLDERS' EQUITY
Number of common stock sold in offering (in shares)					5,513,358
Gross proceeds from sales of stock					$ 21,387,718
Weighted average price of shares issued					$ 3.88
Issuance costs					$ 435,862
Aggregate net proceeds received					$ 20,951,856
Registered direct offering
STOCKHOLDERS' EQUITY
Number of common stock sold in offering (in shares)	4,000,000
Purchase price per share (in dollars per share)	$ 4.5
Gross proceeds from sales of stock	$ 18,000,000
Aggregate net proceeds received	17,488,740
Direct issuance costs incurred	$ 511,260